Skip to content

Adjunctive esketamine for superficial cervical plexus block in carotid endarterectomy: a randomised double-blind study

Adjunctive esketamine to levobupivacaine for ultrasound-guided superficial cervical plexus block in elective carotid endarterectomy: a prospective randomised double-blind controlled trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12626000424303
Enrollment
60
Registered
2026-04-07
Start date
2026-05-11
Completion date
2026-11-02
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This randomized, double-blind controlled trial aims to evaluate the analgesic efficacy and safety of adjunctive esketamine added to a superficial cervical plexus block in patients undergoing carotid endarterectomy. Participants will be randomly assigned to receive either a local anesthetic solution with esketamine or a local anesthetic solution alone. The primary outcome is time to first postoperative rescue analgesic administration. Secondary outcomes include postoperative pain intensity assessed using the Numerical Pain Rating Scale, total postoperative analgesic consumption, and the incidence of esketamine-related adverse effects, including dissociative symptoms assessed with the Clinician-Administered Dissociative States Scale (CADSS-6). The study has received approval from the institutional ethics committee.

Interventions

Intervention group: Ultrasound-guided superficial cervical plexus block performed using perineural injection of 0,5% levobupivacaine (2mg/kg) with the addition of esketamine 25 mg as an adjuvant. The study solution is prepared by an anesthesiologist not involved in patient care or data collection. The block is performed under ultrasound guidance prior to elective carotid endarterectomy. Correct needle placement and local anesthetic spread are confirmed by ultrasound visualization. All procedure

Intervention group: Ultrasound-guided superficial cervical plexus block performed using perineural injection of 0,5% levobupivacaine (2mg/kg) with the addition of esketamine 25 mg as an adjuvant. The study solution is prepared by an anesthesiologist not involved in patient care or data collection. The block is performed under ultrasound guidance prior to elective carotid endarterectomy. Correct needle placement and local anesthetic spread are confirmed by ultrasound visualization. All procedures are performed by experienced anesthesiologists. Administration details are documented in anesthesia records and study documentation. Adherence to the intervention protocol is verified by review of medical records

Sponsors

Sestre Milosrdnice University Hospital Center
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Adult patients (ASA physical status II-III) scheduled for elective carotid endarterectomy under regional anesthesia with superficial cervical plexus block, able to communicate and provide written informed consent.

Exclusion criteria

Known allergy or hypersensitivity to esketamine of levobupovacaine; history of psychiatric disorders or cognitive impairment; inability to communicate or cooperate during the procedure; refusal or inability to provide informed consent.

Outcome results

None listed

Source: ANZCTR · Data processed: Apr 17, 2026